|
Market Closed -
NYSE
00:00:00 12/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.640 USD | -3.30% |
|
-1.12% | +46.67% |
| 08-12 | Protalix BioTherapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -3.30% | -1.12% | +0.76% | +26.32% | +46.67% | +45.86% | +46.67% | +76.00% | -58.10% | 213M | |
| -0.65% | -2.93% | -8.57% | -1.53% | +3.82% | +47.70% | +86.17% | +365.85% | +1,310.85% | 994B | |
| -0.29% | -3.51% | +1.81% | +10.26% | +28.33% | +49.15% | +62.35% | +59.06% | +122.88% | 640B | |
| +0.83% | +0.26% | +3.36% | +12.91% | +12.53% | +17.76% | +72.25% | +141.02% | +301.25% | 454B | |
| -0.38% | -3.59% | -6.70% | +5.81% | +4.88% | +28.24% | +35.57% | +0.06% | +43.42% | 337B | |
| -0.09% | -13.54% | -10.98% | -7.82% | +2.23% | +10.08% | +26.87% | +42.42% | +44.75% | 261B | |
| -0.43% | -2.48% | -1.15% | -13.77% | -15.10% | -2.07% | +11.48% | +43.25% | +142.95% | 246B | |
| -1.34% | -13.70% | -9.33% | +6.24% | +15.29% | +36.53% | +44.96% | +76.54% | +119.34% | 204B | |
| -3.44% | -7.51% | -10.01% | -2.16% | -15.00% | -20.08% | -59.58% | -11.89% | +86.73% | 190B | |
| -0.75% | -4.82% | +5.78% | +14.44% | +17.09% | +25.46% | +87.14% | +102.45% | +82.27% | 178B | |
| +0.25% | -2.57% | +5.36% | +5.76% | +11.33% | +16.13% | -18.83% | -39.20% | -20.00% | 158B | |
| +0.17% | -5.62% | -1.96% | +15.85% | +13.69% | +30.65% | +48.73% | +173.34% | +426.71% | 131B | |
| -0.17% | -4.76% | -0.09% | +11.40% | +17.98% | +37.75% | +5.64% | +0.81% | +13.00% | 130B | |
| -0.42% | -3.93% | -2.86% | -4.35% | -11.44% | -9.22% | -27.95% | -10.52% | +4.73% | 102B | |
| -0.28% | -4.12% | -6.62% | -9.78% | -2.96% | +16.67% | +20.54% | -0.23% | -11.45% | 95.94B | |
| +0.06% | -5.49% | -9.70% | -13.54% | -22.09% | -3.37% | +43.44% | +53.82% | +462.51% | 68.8B | |
| +0.16% | -1.51% | +1.50% | +12.58% | +17.19% | +25.80% | +24.66% | +51.05% | +20.30% | 58.91B | |
| -1.09% | -1.39% | -1.59% | +34.59% | +30.15% | +67.08% | -5.92% | +5.23% | -49.31% | 54.92B | |
| +2.04% | +2.01% | +0.95% | +7.10% | +18.84% | +86.10% | +269.79% | +303.59% | -28.06% | 43.22B | |
| -0.61% | -7.28% | -22.38% | -9.17% | -28.37% | -37.52% | -0.77% | -10.07% | +166.26% | 41.9B | |
| Average | -0.49% | -4.54% | -3.62% | +5.06% | +7.25% | +23.44% | +38.66% | +71.13% | +159.05% | 219.46B | |
| Weighted average by Cap. | -0.41% | -4.31% | -3.63% | +3.55% | +7.91% | +28.72% | +48.45% | +126.27% | +393.18% |
- Stock Market
- Stocks
- PLX Stock
- Sector Protalix BioTherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
